Institute for Pharmaceutical Biology and Biotechnology, University of Düsseldorf, Universitätsstrasse 1, D-40225 Düsseldorf, Germany.
Curr Opin Microbiol. 2013 Oct;16(5):522-30. doi: 10.1016/j.mib.2013.07.006. Epub 2013 Aug 8.
Bacterial resistance to currently applied antibiotics complicates the treatment of infections and demands the evaluation of new strategies to counteract multidrug-resistant bacteria. In recent years, the inhibition of the bacterial divisome, mainly by targeting the central cell division mediator FtsZ, has been recognized as a promising strategy for antibiotic attack. New antibiotics were shown to either interfere with the natural dynamics and functions of FtsZ during the cell cycle or to activate a bacterial protease to degrade FtsZ and thus bring about bacterial death in a suicidal manner. Their efficacy in animal models of infection together with resistance-breaking properties prove the potential of such drugs and validate the inhibition of bacterial cell division as an attractive approach for antibiotic intervention.
细菌对抗生素的耐药性使感染的治疗变得复杂,并需要评估新的策略来对抗多药耐药菌。近年来,抑制细菌的分裂体,主要是通过靶向中央细胞分裂介质 FtsZ,已被认为是抗生素攻击的一种有前途的策略。新的抗生素被证明可以在细胞周期中干扰 FtsZ 的自然动力学和功能,或者激活细菌蛋白酶来降解 FtsZ,从而以自杀的方式导致细菌死亡。它们在感染动物模型中的疗效以及耐药性的突破证明了这些药物的潜力,并验证了抑制细菌分裂作为抗生素干预的一种有吸引力的方法。